Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine5′-monophosphate deaminase inhibitors

被引：0

作者：

Kasibhatla, SR ^{[1
]}

Bookser, BC ^{[1
]}

Appleman, JR ^{[1
]}

Probst, G ^{[1
]}

Xiao, W ^{[1
]}

Fujitaki, JM ^{[1
]}

Erion, MD ^{[1
]}

机构：

[1] Metabasis Therapeut Inc, San Diego, CA 92121 USA

来源：

PURINE AND PYRIMIDINE METABOLISM IN MAN IX | 1998年 / 431卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：849 / 852

页数：4

共 50 条

[41] The first potent inhibitors for human glutaminyl cyclase: Synthesis and structure-activity relationship
Buchholz, M
Heiser, U
Schilling, S
Niestroj, AJ
Zunkel, K
Demuth, HU
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) : 664 - 677
[42] Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD
Strancar, K
Blanot, D
Gobec, S
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 343 - 348
[43] Design, synthesis and structure-activity relationships of tetrahydroquinoline farnesyltransferase inhibitors.
Lombardo, LJ
Bhide, R
Camuso, A
Clark, J
Fager, K
Gullo-Brown, J
Hunt, JT
Inigo, I
Kan, D
Lee, F
Manne, V
McGlinchey, K
Qian, LG
Ricca, C
Rovnyak, G
Sheng, C
Traeger, S
Williams, D
Wu, L
Yang, J
Zhao, YF
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U174 - U175
[44] The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors
Steinman, DH
Curtin, ML
Garland, RB
Davidsen, SK
Heyman, HR
Holms, JH
Albert, DH
Magoc, TJ
Nagy, IB
Marcotte, PA
Li, JL
Morgan, DW
Hutchins, C
Summers, JB
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2087 - 2092
[45] Design, Synthesis, and Structure-Activity Relationships of Azolylmethylpyrroloquinolines as Nonsteroidal Aromatase Inhibitors
Ferlin, Maria Grazia
Carta, Davide
Bortolozzi, Roberta
Ghodsi, Razieh
Chimento, Adele
Pezzi, Vincenzo
Moro, Stefano
Hanke, Nina
Hartmann, Rolf W.
Basso, Giuseppe
Viola, Giampietro
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7536 - 7551
[46] Potent acetylcholinesterase inhibitors: Design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series
Mary, A
Renko, DZ
Guillou, C
Thal, C
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (10) : 1835 - 1850
[47] Structure-activity relationships of selective GABA uptake inhibitors
Hog, Signe
Greenwood, Jeremy R.
Madsen, Karsten B.
Larsson, Orla M.
Frolund, Bente
Schousboe, Arne
Krogsgaard-Larsen, Povl
Clausen, Rasmus P.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (17) : 1861 - 1882
[48] Synthesis and structure-activity relationships of potent thrombin inhibitors: Piperazides of 3-amidinophenylalanine
Sturzebecher, J
Prasa, D
Hauptmann, J
Vieweg, H
Wilkstrom, P
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (19) : 3091 - 3099
[49] Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase α inhibitors
Kuramochi, Kouji
Fukudome, Keishi
Kuriyama, Isoko
Takeuchi, Toshifumi
Sato, Yoshihiro
Kamisuki, Shinji
Tsubaki, Kazunori
Sugawara, Fumio
Yoshida, Hiromi
Mizushina, Yoshiyuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7227 - 7238
[50] Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships
Buckley, GM
Davies, N
Dyke, HJ
Gilbert, PJ
Hannah, DR
Haughan, AF
Hunt, CA
Pitt, WR
Profit, RH
Ray, NC
Richard, MD
Sharpe, A
Taylor, AJ
Whitworth, JM
Williams, SC
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 751 - 754

← 1 2 3 4 5 →